Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Afaq Sarwar who wrote (3440)	4/20/1998 7:10:00 PM
From: sly-1	Read Replies (1) \| Respond to of 3906

FLASH ..... FLASH ..... I notified everyone of the David Faber reports last week ..... look at Motley Fool evening news 4/20/98 Heros section (or this mornings WSJ) .... PFE Vaigra one of the fastest selling drugs EVER in first 2 weeks .... going to put BIG hurt on all other drugs out there for ED ..... why haven't we seen anything on Phase II YET????? ..... Any potential takeover of HVSF is likely to be a mute point now that Viagra is making such a BIG splash ..... who'd want to enter this market now???? Especially with a company like HVSF that has yet to enter Phase II seriously and with a management team that appears dead set on letting the stock run itself into the ground .... IMO ..... I guess we all could have made a nice 11 point + gain on the PFE stock since last Friday morning ..... Woulda, coulda, shoulda - just like I should have sold my HVSF position at $9!!!! Oh well .... in this stock until it hits 0!!!!